☰

David Oakes - Publications

Affiliations: 
University of Rochester, Rochester, NY 
Area:
Biostatistics Biology, Statistics
Tree Info Similar researchers PubMed Report error

58/327 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Siderowf A, Jennings D, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32657461 DOI: 10.1002/Mds.28139  0.308
2019 Anderson KE, Eberly S, Marder KS, Oakes D, Kayson E, Young A, Shoulson I. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study. Clinical Genetics. PMID 31093973 DOI: 10.1111/Cge.13529  0.302
2018 Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C. Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes". Parkinsonism & Related Disorders. PMID 30655161 DOI: 10.1016/J.Parkreldis.2018.12.028  0.323
2018 Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, et al. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial. Journal of the American College of Cardiology. 72: 636-645. PMID 30071993 DOI: 10.1016/j.jacc.2018.04.086  0.385
2018 Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C. Reproducibility of data-driven Parkinson's disease subtypes for clinical research. Parkinsonism & Related Disorders. PMID 30056038 DOI: 10.1016/J.Parkreldis.2018.07.009  0.315
2017 Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD. The CREST-E study of creatine for Huntington disease: A randomized controlled trial. Neurology. PMID 28701493 DOI: 10.1212/Wnl.0000000000004209  0.304
2017 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. Jama Neurology. PMID 28595287 DOI: 10.1001/Jamaneurol.2017.0985  0.335
2017 Biglan KM, Oakes D, Lang AE, Hauser RA, Hodgeman K, Greco B, Lowell J, Rockhill R, Shoulson I, Venuto C, Young D, Simuni T. A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III). Annals of Clinical and Translational Neurology. 4: 360-368. PMID 28589163 DOI: 10.1002/Acn3.412  0.333
2016 Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I. Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease. Movement Disorders Clinical Practice. 3: 53-58. PMID 30363507 DOI: 10.1002/Mdc3.12273  0.307
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.301
2015 Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, ... ... Oakes D, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain : a Journal of Neurology. 138: 2659-71. PMID 26220939 DOI: 10.1093/Brain/Awv202  0.334
2015 Müller ML, Albin RL, Bohnen NI, Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study. Neurology. 84: 2292. PMID 26033339 DOI: 10.1212/Wnl.0000000000001654  0.304
2015 Ravina B, Eberly S, Oakes D, Lang AE, Dodelet V, Roos P, Harman J, Shoulson I, Schipper HM. Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study. Biomarkers in Medicine. 9: 89-97. PMID 25689898 DOI: 10.2217/Bmm.14.103  0.308
2014 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology. 83: 1739-46. PMID 25298306 DOI: 10.1212/Wnl.0000000000000960  0.327
2014 Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A. Mendelian randomization of serum urate and parkinson disease progression. Annals of Neurology. 76: 862-8. PMID 25257975 DOI: 10.1002/Ana.24281  0.339
2014 Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D. Longitudinal follow-up of SWEDD subjects in the PRECEPT Study. Neurology. 82: 1791-7. PMID 24759846 DOI: 10.1212/Wnl.0000000000000424  0.316
2014 Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. Jama Neurology. 71: 543-52. PMID 24664227 DOI: 10.1001/Jamaneurol.2014.131  0.346
2014 Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, et al. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 743-9. PMID 24515275 DOI: 10.1002/Mds.25814  0.343
2014 Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. Jama Neurology. 71: 141-50. PMID 24366103 DOI: 10.1001/Jamaneurol.2013.5528  0.351
2013 Lang AE, Eberly S, Goetz CG, Stebbins G, Oakes D, Marek K, Ravina B, Tanner CM, Shoulson I. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1980-6. PMID 24123383 DOI: 10.1002/Mds.25671  0.33
2013 Moscovitch-Lopatin M, Goodman RE, Eberly S, Ritch JJ, Rosas HD, Matson S, Matson W, Oakes D, Young AB, Shoulson I, Hersch SM. HTRF analysis of soluble huntingtin in PHAROS PBMCs. Neurology. 81: 1134-40. PMID 23966247 DOI: 10.1212/Wnl.0B013E3182A55Ede  0.309
2013 Marras C, Oakes D. Author reply to Holford, Vu and Nutt regarding 'piecing together the puzzle of progression and mortality in Parkinson's disease' British Journal of Clinical Pharmacology. 75: 1372. PMID 22989073 DOI: 10.1111/J.1365-2125.2012.04464.X  0.315
2012 Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1392-7. PMID 22976926 DOI: 10.1002/Mds.25157  0.33
2012 Paumier KL, Siderowf AD, Auinger P, Oakes D, Madhavan L, Espay AJ, Revilla FJ, Collier TJ. Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 880-7. PMID 22555881 DOI: 10.1002/Mds.24978  0.334
2012 Marras C, Oakes D. Piecing together the puzzle of progression and mortality in Parkinson's disease British Journal of Clinical Pharmacology. 74: 264-266. PMID 22554391 DOI: 10.1111/J.1365-2125.2012.04315.X  0.391
2011 Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H. Serum cholesterol and the progression of parkinson's disease: Results from DATATOP Plos One. 6. PMID 21853051 DOI: 10.1371/Journal.Pone.0022854  0.316
2011 Schwarzschild MA, Marek K, Eberly S, Oakes D, Shoulson I, Jennings D, Seibyl J, Ascherio A. Serum urate and probability of dopaminergic deficit in early "Parkinson's disease". Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1864-8. PMID 21538532 DOI: 10.1002/Mds.23741  0.322
2010 Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I, Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, et al. Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1801-8. PMID 20669311 DOI: 10.1002/Mds.23006  0.317
2010 Oakes D, Feng C. Combining stratified and unstratified log-rank tests in paired survival data Statistics in Medicine. 29: 1735-1745. PMID 20572124 DOI: 10.1002/Sim.3921  0.49
2009 Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I. A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2370-8. PMID 19908310 DOI: 10.1002/Mds.22828  0.38
2009 Hauser RA, Auinger P, Oakes D. Levodopa response in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2328-36. PMID 19908302 DOI: 10.1002/Mds.22759  0.336
2009 Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, ... Oakes D, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Archives of Neurology. 66: 1460-8. PMID 19822770 DOI: 10.1001/Archneurol.2009.247  0.334
2009 Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2081-90. PMID 19691116 DOI: 10.1002/Mds.22690  0.338
2009 Simuni T, Biglan K, Oakes D, Gardiner N, Deeley C, Surmeier D. P2.161 STEADY-PD: safety, tolerability, and efflcacy assessment of isradipine (Dynacirc CR) in early Parkinson disease Parkinsonism & Related Disorders. 15: S133. DOI: 10.1016/S1353-8020(09)70512-7  0.302
2008 Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 71: 481-5. PMID 18695158 DOI: 10.1212/01.Wnl.0000324862.29733.69  0.344
2008 Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clinical Neuropharmacology. 31: 127-33. PMID 18520979 DOI: 10.1097/Wnf.0B013E3180Ca77Ea  0.319
2008 Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Archives of Neurology. 65: 716-23. PMID 18413464 DOI: 10.1001/Archneur.2008.65.6.Nct70003  0.347
2008 Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 874-80. PMID 18096682 DOI: 10.1136/Jnnp.2007.128728  0.319
2008 Wang A, Oakes D. Some properties of the Kendall distribution in bivariate Archimedean copula models under censoring Statistics and Probability Letters. 78: 2578-2583. DOI: 10.1016/J.Spl.2008.07.018  0.497
2006 Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E. Preparing for preventive clinical trials: the Predict-HD study. Archives of Neurology. 63: 883-90. PMID 16769871 DOI: 10.1001/Archneur.63.6.883  0.343
2006 Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210  0.345
2006 Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/Mds.20764  0.319
2005 Chou KL, Messing S, Oakes D, Feldman PD, Breier A, Friedman JH. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clinical Neuropharmacology. 28: 215-9. PMID 16239760 DOI: 10.1097/01.Wnf.0000180228.77802.32  0.33
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/Mds.20332  0.305
2004 Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K. Levodopa and the progression of Parkinson's disease. The New England Journal of Medicine. 351: 2498-508. PMID 15590952 DOI: 10.1056/Nejmoa033447  0.344
2003 Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, Shults CW, Stoessl AJ. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease Experimental Neurology. 184. PMID 14597329 DOI: 10.1016/J.Expneurol.2003.08.008  0.309
2003 Reider CR, Halter CA, Castelluccio PF, Oakes D, Nichols WC, Foroud T. Reliability of reported age at onset for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 275-9. PMID 12621630 DOI: 10.1002/Mds.10391  0.309
2003 Oakes D, Wang A. Copula model generated by Dabrowska's association measure Biometrika. 90: 478-481. DOI: 10.1093/Biomet/90.2.478  0.495
2002 Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/Archneur.59.12.1937  0.367
2002 Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/Archneur.59.10.1541  0.334
2002 Shoulson I, Oakes D, Fahn S, Lang A, Langston JW, LeWitt P, Olanow CW, Penney JB, Tanner C, Kieburtz K, Rudolph A. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Annals of Neurology. 51: 604-12. PMID 12112107 DOI: 10.1002/Ana.10191  0.349
2001 Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial Movement Disorders. 16: 135-139. PMID 11215574 DOI: 10.1002/1531-8257(200101)16:1<135::Aid-Mds1006>3.0.Co;2-Q  0.356
1998 Kieburtz K, Frey K, Albin R, Marek K, Bates G, Aylward E, Guttman M, Rouleau G, Baehr M, Pahwa R, Lyons KE, Wilkinson SB, Kieltyka J, Koller WC, Bertoni JM, ... ... Oakes D, et al. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis, and Treatment of Huntington's Disease, Queen Elizabeth Hotel, Montreal, Canada, 18 October 1998 Movement Disorders. 13: 858-863. DOI: 10.1002/Mds.870130522  0.307
1997 LeWitt P, Oakes D, Cui L. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol Movement Disorders. 12: 183-189. PMID 9087976 DOI: 10.1002/Mds.870120208  0.36
1996 Penney JB, Oakes D, Shoulson I, Fahn S, Lang A, William Langston J, LeWitt P, Warren Olanow C, Tanner C, Kieburtz K. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa Annals of Neurology. 39: 37-45. PMID 8572664 DOI: 10.1002/Ana.410390107  0.352
1990 Oakes D, McDermott M, Eberly S, Plumb S, Watts A, Shoulson I. ·P-17 Investigator effects in a multicenter trial for parkinson's disease Controlled Clinical Trials. 11: 284. DOI: 10.1016/0197-2456(90)90116-J  0.336
1989 Shoulson I, Odoroff C, Oakes D, Behr J, Goldblatt D, Caine E, Kennedy J, Miller C, Bamford K, Rubin A, Plumb S, Kurlan R. A controlled clinical trial of baclofen as protective therapy in early Huntington's disease. Annals of Neurology. 25: 252-259. PMID 2524992 DOI: 10.1002/Ana.410250308  0.327
1986 Oakes D. Semiparametric inference in a model for association in bivanate survival data Biometrika. 73: 353-361. DOI: 10.1093/Biomet/73.2.353  0.302
Low-probability matches (unlikely to be authored by this person)
2006 Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. Annals of Neurology. 60: 65-72. PMID 16718702 DOI: 10.1002/Ana.20882  0.3
2002 McDermott MP, Hall WJ, Oakes D, Eberly S. Design and analysis of two-period studies of potentially disease-modifying treatments. Controlled Clinical Trials. 23: 635-49. PMID 12505242 DOI: 10.1016/S0197-2456(02)00238-6  0.299
2016 Oakes D. On the win-ratio statistic in clinical trials with multiple types of event Biometrika. 103: 742-745. DOI: 10.1093/Biomet/Asw026  0.299
2013 Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 80: 2022-7. PMID 23624566 DOI: 10.1212/Wnl.0B013E318294B304  0.299
2012 Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 406-12. PMID 22237833 DOI: 10.1002/Mds.24892  0.297
2007 Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, et al. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement Disorders. 22: 254-257. PMID 17149721 DOI: 10.1002/Mds.21233  0.296
2012 Killoran A, Biglan K, Jankovic J, Eberly S, Kayson E, Oakes D, Young A, Shoulson I. Analysis of the Behavioral Features Conferred by the Intermediate Allele for Huntington Disease in the Prospective Huntington at Risk Observational Study (PHAROS) (PL01.003) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pl01.003  0.295
2015 Oster E, Eberly SW, Dorsey ER, Kayson-Rubin E, Oakes D, Shoulson I. Informativeness of Early Huntington Disease Signs about Gene Status. Journal of Huntington's Disease. 4: 271-7. PMID 26444024 DOI: 10.3233/Jhd-150156  0.294
1994 Oakes D. On the consistency of a test for symmetry based on a runs statistic Journal of Nonparametric Statistics. 3: 343-354. DOI: 10.1080/10485259408832593  0.294
2016 Quaid KA, Eberly SW, Kayson-Rubin E, Oakes D, Shoulson I. Factors Related to Genetic Testing in Adults at Risk for Huntington Disease: The Prospective Huntington At-Risk Observational Study (PHAROS). Clinical Genetics. PMID 27740685 DOI: 10.1111/Cge.12893  0.294
1989 Oakes D. Bivariate survival models induced by frailties Journal of the American Statistical Association. 84: 487-493. DOI: 10.1080/01621459.1989.10478795  0.291
2006 Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I. Safety of rasagiline in elderly patients with Parkinson disease. Neurology. 66: 1427-9. PMID 16682679 DOI: 10.1212/01.Wnl.0000210692.95595.1C  0.29
2004 Shults CW, Haas R, Oakes D, Kieburtz K, Plumb S, Shoulson I, Beal MF, Juncos J, Nutt J. Measuring the effects of therapy in Parkinson disease. Jama. 291: 2430-1; author reply. PMID 15161889 DOI: 10.1001/Jama.291.20.2430-B  0.289
2008 Oakes D, Peterson DR. Survival methods: additional topics. Circulation. 117: 2949-55. PMID 18519862 DOI: 10.1161/Circulationaha.107.700377  0.289
1982 Oakes D. A concordance test for independence in the presence of censoring Biometrics. 38: 451-455. PMID 7052151 DOI: 10.2307/2530458  0.288
2011 Dorsey R, Biglan K, Eberly S, Auinger P, Brocht A, Umeh CC, Oakes D, Clarence-Smith K, Marshall F, Shoulson I, Frank S. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. Plos Currents. 3: RRN1283. PMID 22139861 DOI: 10.1371/Currents.Rrn1283  0.287
1999 Manatunga AK, Oakes D. Parametric Analysis for Matched Pair Survival Data Lifetime Data Analysis. 5: 371-387. PMID 10650743 DOI: 10.1023/A:1009692210273  0.287
1992 LeWitt PA, Galloway MP, Matson W, Milbury P, McDermott M, Srivastava DK, Oakes D. Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group. Neurology. 42: 2111-7. PMID 1436520 DOI: 10.1212/Wnl.42.11.2111  0.286
2018 Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I. Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29297592 DOI: 10.1002/Mds.27239  0.285
2007 Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, ... Oakes D, et al. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia. 45: 1767-76. PMID 17303196 DOI: 10.1016/J.Neuropsychologia.2006.12.015  0.284
1990 Benhorin J, Moss AJ, Oakes D. Prognostic significance of nonfatal myocardial reinfarction Journal of the American College of Cardiology. 15: 253-258. PMID 2299062 DOI: 10.1016/S0735-1097(10)80043-9  0.284
2001 Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology. 57: 2089-94. PMID 11739831 DOI: 10.1212/Wnl.57.11.2089  0.283
1977 Oakes D. The asymptotic information in censored survival data Biometrika. 64: 441-448. DOI: 10.1093/Biomet/64.3.441  0.282
2013 Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. Jama Neurology. 70: 1382-8. PMID 24000094 DOI: 10.1001/Jamaneurol.2013.3487  0.281
2017 Weintraub D, Chahine LM, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition and the course of prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29063713 DOI: 10.1002/Mds.27189  0.279
2016 Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, et al. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. Jama. 316: 40-50. PMID 27380342 DOI: 10.1001/Jama.2016.8655  0.278
1993 Oakes D, Moss AJ, Fleiss JL, Bigger JT, Therneau T, Eberly SW, McDermott MP, Manatunga A, Carleen E, Benhorin J. Use of Compliance Measures in an Analysis of the Effect of Diltiazem on Mortality and Reinfarction After Myocardial Infarction Journal of the American Statistical Association. 88: 44-49. DOI: 10.1080/01621459.1993.10594287  0.277
1995 Oakes D. Multiple time scales in survival analysis Lifetime Data Analysis. 1: 7-18. PMID 9385093 DOI: 10.1007/Bf00985253  0.277
2009 Sabine C, Trembath K, Churchyard A, Horton Z, Tippett L, Hogg V, Roxburgh R, Velakoulis D, Collins V, Delatycki M, Aylward E, Nopoulos P, Johnson H, Juhl A, Magnotta V, ... ... Oakes D, et al. Second Annual Huntington Disease Clinical Research Symposium Neurotherapeutics. 6: 202-212. DOI: 10.1016/J.Nurt.2008.09.004  0.277
1982 Fawer RF, Ward Gardner A, Oakes D. Absences attributed to respiratory diseases in welders British Journal of Industrial Medicine. 39: 149-152. PMID 7066231 DOI: 10.1136/Oem.39.2.149  0.276
1990 Reichman RC, Oakes D, Bonnez W, Brown D, Mattison HR, Bailey-Farchione A, Stoler MH, Demeter LM, Tyring SK, Miller L. Treatment of condyloma acuminatum with three different interferon-alpha preparations administered parenterally: a double-blind, placebo-controlled trial. The Journal of Infectious Diseases. 162: 1270-6. PMID 2172401 DOI: 10.1093/Infdis/162.6.1270  0.276
2005 Paulsen JS, Stout JC, Aylward E, Kieburtz K, Langbehn D, Ross C, Hayden M, Guttman M, Nance M, Oakes D. [P-058]: Early detection of dementia in Huntington's disease: The Predict-HD study Alzheimer's & Dementia. 1: S26-S26. DOI: 10.1016/J.Jalz.2005.06.132  0.273
2013 Oakes D. An introduction to survival models: In honor of Ross Prentice Lifetime Data Analysis. 19: 442-462. PMID 23832309 DOI: 10.1007/S10985-013-9276-2  0.273
2014 Jennings D, Eberly S, Oakes D, Seibyl J, Marek K, Shoulson I. Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial. Journal of Parkinson's Disease. 4: 629-38. PMID 25062961 DOI: 10.3233/Jpd-140383  0.272
2007 Tanner C, Comella C, Kamp C, Kieburtz K, Oakes D, Marshall F, Day D, Carter J, Pahwa R, Shoulson I, Truong D, Tran AH, Thompson K, Shulman LM, Rodriguez D, et al. Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage Clinical Neuropharmacology. 30: 72-85. PMID 17414939 DOI: 10.1097/01.Wnf.0000240943.59617.4C  0.272
2005 Jeong JH, Oakes D. Effects of different hazard ratios on asymptotic relative efficiency of estimates from Cox's model Communications in Statistics - Theory and Methods. 34: 429-448. DOI: 10.1080/03610920509342431  0.271
2009 Oster E, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K, Dorsey ER. Poster 21: Insurance Ownership and Genetic Risk Neurotherapeutics. 6: 210-211. DOI: 10.1016/J.Nurt.2008.10.025  0.271
2013 Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA. Caffeine consumption and risk of dyskinesia in CALM-PD. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 380-3. PMID 23339054 DOI: 10.1002/Mds.25319  0.269
2000 Miller Watelet LF, Moss AJ, Zareba W, Oakes D, Ryan D. Detection of a group of risk factors in coronary disease using a new carriership analysis approach American Journal of Cardiology. 86: 1253-1256. PMID 11090802 DOI: 10.1016/S0002-9149(00)01213-3  0.269
2010 Moser K, Biglan KM, Ross CA, Langbehn DR, Aylward E, Stout JC, Queller S, Carlozzi N, Duff K, Beglinger LJ, Paulsen JS, Tomusk A, Lifer S, Hastings S, Dawson J, ... ... Oakes D, et al. Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group Neurotherapeutics. 5: 202-212. DOI: 10.1016/J.Nurt.2007.10.053  0.268
1982 Oakes D. A Model for Association in Bivariate Survival Data Journal of the Royal Statistical Society Series B-Methodological. 44: 414-422. DOI: 10.1111/J.2517-6161.1982.Tb01222.X  0.268
1992 Oakes D, Manatunga AK. A new representation of Cox's score statistic and its variance Statistics and Probability Letters. 14: 107-110. DOI: 10.1016/0167-7152(92)90072-D  0.266
1997 Bonnez W, Oakes D, Bailey-Farchione A, Choi A, Hallahan D, Corey L, Barnum G, Pappas PG, Halloway M, Stoler MH, Reichman RC. A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum. Antiviral Research. 35: 41-52. PMID 9224960 DOI: 10.1016/S0166-3542(97)01037-1  0.266
2008 Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K. Fear of health insurance loss among individuals at risk for Huntington disease. American Journal of Medical Genetics. Part A. 146: 2070-7. PMID 18627059 DOI: 10.1002/Ajmg.A.32422  0.265
1990 Jackson Hall W, Oakes D. Statistical issues in monitoring a 2 × 2 factorial clinical trial Controlled Clinical Trials. 11: 264. DOI: 10.1016/0197-2456(90)90066-B  0.264
1983 Oakes D. Comparison of models for survival data Statistics in Medicine. 2: 305-311. PMID 6648145 DOI: 10.1002/Sim.4780020227  0.264
2009 Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Stodgell CJ, Dworkin RH. The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness. Obstetrics and Gynecology. 113: 825-32. PMID 19305326 DOI: 10.1097/Aog.0B013E31819Bda7C  0.264
1993 Oakes D. A note on the kaplan-meier estimator American Statistician. 47: 39-40. DOI: 10.1080/00031305.1993.10475931  0.263
2010 Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Poleshuck EL, Stodgell CJ, Dworkin RH. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstetrics and Gynecology. 116: 583-93. PMID 20733439 DOI: 10.1097/Aog.0B013E3181E9E0Ab  0.263
1998 Oakes D, Jeong JH. Frailty Models and Rank Tests Lifetime Data Analysis. 4: 209-228. PMID 9787603 DOI: 10.1023/A:1009689630516  0.262
2005 Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, et al. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. The American Journal of Cardiology. 96: 177-82. PMID 16018837 DOI: 10.1016/J.Amjcard.2005.03.039  0.261
1995 Bonnez W, Oakes D, Bailey-Farchione A, Choi A, Hallahan D, Pappas P, Holloway M, Corey L, Barnum G, Dunne A, Stoler MH, Demeter LM, Reichman RC. A Randomized, Double-Blind, Placebo-Controlled Trial of Systemically Administered Interferon-α, -β, or -γ in Combination with Cryotherapy for the Treatment of Condyloma Acuminatum The Journal of Infectious Diseases. 171: 1081-1089. PMID 7538546 DOI: 10.1093/Infdis/171.5.1081  0.26
2004 Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Archives of Neurology. 61: 1224-9. PMID 15313838 DOI: 10.1001/Archneur.61.8.1224  0.26
1991 Moss AJ, Oakes D, Rubison M, McDermott M, Carleen E, Eberly S, Brown M. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension American Journal of Cardiology. 68: 429-433. PMID 1872266 DOI: 10.1016/0002-9149(91)90773-E  0.26
2019 Shoulson I, Eberly S, Oakes D, Kayson E, Young AB. Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study. Annals of Clinical and Translational Neurology. 6: 1046-1052. PMID 31211168 DOI: 10.1002/Acn3.781  0.259
2008 Oakes D. On consistency of Kendall's tau under censoring Biometrika. 95: 997-1001. DOI: 10.1093/Biomet/Asn037  0.257
2006 Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, et al. Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease Movement Disorders. 21: 2257-2260. PMID 17078063 DOI: 10.1002/Mds.21162  0.257
2015 Frampton MW, Pietropaoli A, Dentler M, Chalupa D, Little EL, Stewart J, Frasier L, Oakes D, Wiltshire J, Vora R, Utell MJ. Cardiovascular effects of ozone in healthy subjects with and without deletion of glutathione-S-transferase M1. Inhalation Toxicology. 27: 113-9. PMID 25600221 DOI: 10.3109/08958378.2014.996272  0.256
1997 Emond MJ, Ritz J, Oakes D. Bias in gee estimates from misspecified models for longitudinal data Communications in Statistics - Theory and Methods. 26: 15-32. DOI: 10.1080/03610929708831899  0.256
1986 Oakes D. An approximate likelihood procedure for censored data Biometrics. 42: 177-182. PMID 3719053 DOI: 10.2307/2531253  0.256
1988 Reichman RC, Oakes D, Bonnez W, Greisberger C, Tyring S, Miller L, Whitley R, Carveth H, Weidner M, Krueger G. Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 108: 675-9. PMID 3358568 DOI: 10.7326/0003-4819-108-5-675  0.256
1976 Oakes D. Random Overlapping Intervals--A Generalization of Erlang's Loss Formula Annals of Probability. 4: 940-946. DOI: 10.1214/Aop/1176995938  0.255
2001 Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, Abwender D, Greenarnyre JT, Higgins D, Marshall FJ, Goldstein J, Steinberg K, Shih C, Richard I, Hickey C, ... ... Oakes D, et al. Unified huntington’s disease rating scale: Reliability and consistency Neurology. 11: 136-142. PMID 8684382 DOI: 10.1002/Mds.870110204  0.255
1992 Boden WE, Moss AJ, Oakes D. Hypolipidemic effect of type Ia antiarrhythmic agents in postinfarction patients Circulation. 85: 2039-2044. PMID 1591822 DOI: 10.1161/01.Cir.85.6.2039  0.255
2019 Breitner S, Peters A, Zareba W, Hampel R, Oakes D, Wiltshire J, Frampton MW, Hopke PK, Cyrys J, Utell MJ, Kane C, Schneider A, Rich DQ. Ambient and controlled exposures to particulate air pollution and acute changes in heart rate variability and repolarization. Scientific Reports. 9: 1946. PMID 30760868 DOI: 10.1038/S41598-019-38531-9  0.254
2004 Manatunga AK, Oakes D. Efficiency of independence working analysis of correlated survival data with general cluster size Statistica Neerlandica. 58: 313-321. DOI: 10.1111/J.1467-9574.2004.00124.X  0.253
2012 Frampton MW, Bausch J, Chalupa D, Hopke PK, Little EL, Oakes D, Stewart JC, Utell MJ. Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes Inhalation Toxicology. 24: 831-838. PMID 23033996 DOI: 10.3109/08958378.2012.724117  0.253
2008 Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K. Influence of Insurance on the Decision to Pursue Genetic Testing in Individuals at Risk for Huntington’s Disease Neurotherapeutics. 5: 368-368. DOI: 10.1016/J.Nurt.2007.10.017  0.251
2012 Rich DQ, Zareba W, Beckett W, Hopke PK, Oakes D, Frampton MW, Bisognano J, Chalupa D, Bausch J, O'Shea K, Wang Y, Utell MJ. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environmental Health Perspectives. 120: 1162-1169. PMID 22542955 DOI: 10.1289/Ehp.1104262  0.25
1996 Manatunga AK, Oakes D. A measure of association for bivariate frailty distributions Journal of Multivariate Analysis. 56: 60-74. DOI: 10.1006/Jmva.1996.0004  0.248
2007 Johnson SA, Stout JC, Solomon AC, Langbehn DR, Aylward EH, Cruce CB, Ross CA, Nance M, Kayson E, Julian-Baros E, Hayden MR, Kieburtz K, Guttman M, Oakes D, Shoulson I, et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain : a Journal of Neurology. 130: 1732-44. PMID 17584778 DOI: 10.1093/Brain/Awm107  0.248
2003 Howard CR, Howard FM, Lanphear B, Eberly S, deBlieck EA, Oakes D, Lawrence RA. Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding. Pediatrics. 111: 511-8. PMID 12612229 DOI: 10.1542/Peds.111.3.511  0.248
2004 Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. Journal of Thrombosis and Haemostasis : Jth. 2: 718-25. PMID 15099276 DOI: 10.1111/J.1538-7836.2004.00658.X  0.247
1990 Fleiss JL, Bigger JT, McDermott M, Miller JP, Moon T, Moss AJ, Oakes D, Rolnitzky LM, Therneau TM. Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology. Circulation. 81: 684-685. PMID 2297869 DOI: 10.1161/01.Cir.81.2.684  0.247
1999 Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, et al. Thrombogenic factors and recurrent coronary events. Circulation. 99: 2517-22. PMID 10330382 DOI: 10.1161/01.Cir.99.19.2517  0.245
1985 Douglas DB, Douglas RB, Oakes D, Scott G. Pulmonary function of London firemen British Journal of Industrial Medicine. 42: 55-58. PMID 3965016 DOI: 10.1136/Oem.42.1.55  0.243
1982 Oakes D, Douglas R, Knight K, Wusteman M, Mcdonald JC. Respiratory effects of prolonged exposure to gypsum dust Annals of Occupational Hygiene. 26: 833-840. PMID 7181310 DOI: 10.1093/Annhyg/26.8.833  0.243
1985 Newhouse ML, Oakes D, Woolley AJ. Mortality of welders and other craftsmen at a shipyard in NE England. British Journal of Industrial Medicine. 42: 406-10. PMID 4005194 DOI: 10.1136/Oem.42.6.406  0.243
2019 Kayson E, Eberly S, Anderson KE, Marder K, Shoulson I, Oakes D, Young AB, Biglan K, Hersch S. The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation. Journal of Huntington's Disease. PMID 31381523 DOI: 10.3233/Jhd-190365  0.243
2009 Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants. Neurology. 73: 385-92. PMID 19652143 DOI: 10.1212/Wnl.0B013E3181B04Aa2  0.242
1979 Oakes D. Matched Pairs In Independent Poisson Processes Journal of Applied Probability. 16: 780-793. DOI: 10.1017/S0021900200033477  0.241
2002 Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells, Molecules & Diseases. 29: 41-7. PMID 12482402 DOI: 10.1006/Bcmd.2002.0536  0.24
1981 Oakes D. [Survival Times: Aspects of Partial Likelihood]: Reply to Discussion International Statistical Review. 49: 262. DOI: 10.2307/1402612  0.24
1981 Oakes D. Survival Times: Aspects of Partial Likelihood International Statistical Review. 49: 235. DOI: 10.2307/1402606  0.24
2001 Oakes D. Biometrika centenary: Survival analysis Biometrika. 88: 99-142. DOI: 10.1093/Biomet/88.1.99  0.24
2012 Oakes D. Frailty Models in Survival Analysis by WIENKE, A Biometrics. 68: 657-658. DOI: 10.1111/J.1541-0420.2012.01769.X  0.239
2015 Benhorin J, Bodenheimer M, Brown M, Case R, Dwyer EM, Eberly S, Francis C, Gillespie JA, Goldstein RE, Greenberg H, Haigney M, Krone RJ, Klein H, Lichstein E, Locati E, ... ... Oakes D, et al. Improving clinical practice guidelines for practicing cardiologists. The American Journal of Cardiology. 115: 1773-6. PMID 25918027 DOI: 10.1016/J.Amjcard.2015.03.026  0.238
2009 Constantinescu R, Romer M, Oakes D, Rosengren L, Kieburtz K. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease. Parkinsonism & Related Disorders. 15: 245-8. PMID 19056308 DOI: 10.1016/J.Parkreldis.2008.05.012  0.236
1979 Oakes D. On Log‐Linear Hazards Journal of the Royal Statistical Society Series B-Methodological. 41: 274-275. DOI: 10.1111/J.2517-6161.1979.Tb01083.X  0.235
2010 Pietropaoli AP, Glance LG, Oakes D, Fisher SG. Gender differences in mortality in patients with severe sepsis or septic shock. Gender Medicine. 7: 422-37. PMID 21056869 DOI: 10.1016/J.Genm.2010.09.005  0.235
1986 Schoenfeld D, Cox DR, Oakes D. Analysis of Survival Data. Journal of the American Statistical Association. 81: 572. DOI: 10.2307/2289259  0.234
1985 Breslow N, Cox DR, Oakes D. Analysis of Survival Data. Biometrics. 41: 593. DOI: 10.2307/2530888  0.234
2017 Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, ... ... Oakes D, et al. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. Jama Neurology. PMID 28692723 DOI: 10.1001/Jamaneurol.2017.1352  0.232
1980 Greenfield T, Anderson S, Auquier A, Hauck WW, Oakes D, Vandaele W, Weisberg HI. Statistical Methods for Comparative Studies The Statistician. 30: 235-236. DOI: 10.2307/2988054  0.232
1985 Bazas T, Oakes D, Gilson JC, Bazas B, McDonald JC. Pleural calcification in northwest Greece Environmental Research. 38: 239-247. PMID 4065074 DOI: 10.1016/0013-9351(85)90088-X  0.23
1988 Stewart S, Alexson C, Manning J, Oakes D, Eberly SW. Long-term palliation with the classic Blalock-Taussig shunt Journal of Thoracic and Cardiovascular Surgery. 96: 117-121. PMID 2455199 DOI: 10.1016/S0022-5223(19)35304-8  0.23
2014 Wasserman EB, Zareba W, Utell MJ, Oakes D, Hopke PK, Frampton M, Chalupa D, Beckett W, Rich DQ. Acute Changes in Ambient Temperature Are Associated With Adverse Changes in Cardiac Rhythm. Air Quality, Atmosphere, & Health. 7: 357-367. PMID 25368681 DOI: 10.1007/S11869-014-0244-0  0.229
1974 Daley DJ, Oakes D. Random walk point processes Zeitschrift FüR Wahrscheinlichkeitstheorie Und Verwandte Gebiete. 30: 1-16. DOI: 10.2307/1426263  0.229
1988 Newhouse ML, Matthews G, Sheikh K, Knight KL, Oakes D, Sullivan KR. Mortality of workers at acetylene production plants. British Journal of Industrial Medicine. 45: 63-9. PMID 3342189 DOI: 10.1136/Oem.45.1.63  0.228
1990 Pelusio RM, Rudolph A, Orme C, Evans P, Plumb S, Oakes D, Shoulson I. ·P-64 Data top: Managing an accelerated trial Controlled Clinical Trials. 11: 304. DOI: 10.1016/0197-2456(90)90162-U  0.228
2020 Schneider RB, Omberg L, Macklin EA, Daeschler M, Bataille L, Anthwal S, Myers TL, Baloga E, Duquette S, Snyder P, Amodeo K, Tarolli CG, Adams JL, Callahan KF, Gottesman J, ... ... Oakes D, et al. Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). Annals of Clinical and Translational Neurology. PMID 33350601 DOI: 10.1002/acn3.51236  0.227
2021 Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, et al. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. Jama. 326: 926-939. PMID 34519802 DOI: 10.1001/jama.2021.10207  0.225
1990 Oakes D, Dasu T. A note on residual life Biometrika. 77: 409-410. DOI: 10.1093/Biomet/77.2.409  0.225
2001 Lichtman MA, Oakes D. The productivity and impact of The Leukemia & Lymphoma Society scholar program: The apparent positive effect of peer review Blood Cells, Molecules, and Diseases. 27: 1020-1027. PMID 11831869 DOI: 10.1006/Bcmd.2001.0476  0.225
1976 Oakes D. Bivariate Markov processes of intervals Information and Control. 32: 231-241. DOI: 10.1016/S0019-9958(76)90236-9  0.225
1991 Boden WE, Krone RJ, Kleiger RE, Oakes D, Greenberg H, Dwyer EJ, Miller JP, Abrams J, Coromilas J, Goldstein R, Moss AJ. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction American Journal of Cardiology. 67: 335-342. PMID 1994656 DOI: 10.1016/0002-9149(91)90038-M  0.222
1999 Oakes D. Direct calculation of the information matrix via the EM Journal of the Royal Statistical Society Series B-Statistical Methodology. 61: 479-482. DOI: 10.1111/1467-9868.00188  0.221
2013 Moss AJ, Greenberg H, Dwyer EM, Klein H, Ryan D, Francis C, Marcus F, Eberly S, Benhorin J, Bodenheimer M, Brown M, Case R, Gillespie J, Goldstein R, Haigney M, ... ... Oakes D, et al. Senior academic physicians and retirement considerations. Progress in Cardiovascular Diseases. 55: 611-5. PMID 23621971 DOI: 10.1016/J.Pcad.2013.02.002  0.221
2005 Oakes D. On the preservation of copula structure under truncation Canadian Journal of Statistics. 33: 465-468. DOI: 10.1002/Cjs.5540330310  0.219
2021 Surmeier DJ, Nguyen JT, Lancki N, Venuto CS, Oakes D, Simuni T, Wyse RK. Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34766657 DOI: 10.1002/mds.28850  0.218
2016 Wang M, Utell MJ, Schneider A, Zareba W, Frampton MW, Oakes D, Hopke PK, Wiltshire J, Kane C, Peters A, Breitner S, Chalupa D, Rich DQ. Does total antioxidant capacity modify adverse cardiac responses associated with ambient ultrafine, accumulation mode, and fine particles in patients undergoing cardiac rehabilitation? Environmental Research. 149: 15-22. PMID 27174779 DOI: 10.1016/J.Envres.2016.04.031  0.218
1975 Oakes D. The Markovian Self-Exciting Process Journal of Applied Probability. 12: 69-77. DOI: 10.2307/3212408  0.216
2018 Oakes D. Survival models and health sequences: discussion. Lifetime Data Analysis. PMID 29995260 DOI: 10.1007/S10985-018-9441-8  0.214
2002 Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, Miller Watelet LF, Arora R, Brown MW, Case RB, Dwyer EM, Gillespie JA, Goldstein RE, Greenberg H, Hochman J, ... ... Oakes D, et al. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. The American Journal of Cardiology. 89: 216-21. PMID 11792346 DOI: 10.1016/S0002-9149(01)02204-4  0.213
2014 Vora R, Zareba W, Utell MJ, Pietropaoli AP, Chalupa D, Little EL, Oakes D, Bausch J, Wiltshire J, Frampton MW. Inhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetes Particle and Fibre Toxicology. 31. PMID 25028096 DOI: 10.1186/S12989-014-0031-Y  0.213
1990 Benhorin J, Moss AJ, Oakes D, Marcus F, Greenberg H, Dwyer EM, Algeo S, Hahn E. The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location Journal of the American College of Cardiology. 15: 1201-1207. PMID 2184180 DOI: 10.1016/S0735-1097(10)80001-4  0.211
1974 Hawkes AG, Oakes D. A cluster process representation of a self-exciting process Journal of Applied Probability. 11: 493-503. DOI: 10.2307/3212693  0.21
1990 Oakes D, McDermott M, Eberly S, Plumb S, Watts A, Shoulson I. ·P-17 Investigator effects in a multicenter trial for parkinson's disease Controlled Clinical Trials. 11: 284.  0.208
1981 Wall LM, Oakes D, Rycroft RJG. Virus warts in meat handlers Contact Dermatitis. 7: 259-267. PMID 7307481 DOI: 10.1111/J.1600-0536.1981.Tb04061.X  0.204
2002 Kurlan R, Goetz CG, McDermott MP, Plumb S, Singer H, Dure L, Como P, Sallee FR, Budman C, Coffey B, Juncos J, Mink J, Stebbins G, Tuite P, Seeberger L, ... ... Oakes D, et al. Treatment of ADHD in children with tics: A randomized controlled trial Neurology. 58: 527-536. PMID 11865128 DOI: 10.1212/Wnl.58.4.527  0.203
2021 Venuto CS, Yang L, Javidnia M, Oakes D, James Surmeier D, Simuni T. Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's disease. Annals of Clinical and Translational Neurology. PMID 33460320 DOI: 10.1002/acn3.51300  0.203
2023 Marras C, Arbatti L, Hosamath A, Amara A, Anderson KE, Chahine LM, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Tanner CM, Weintraub D, et al. What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). Journal of Parkinson's Disease. PMID 37334615 DOI: 10.3233/JPD-225083  0.201
1996 Bonnez W, Oakes D, Choi A, d'Arcy SJ, Pappas PG, Corey L, Stoler MH, Demeter LM, Reichman RC. Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatum. Sexually Transmitted Diseases. 23: 273-6. PMID 8836019 DOI: 10.1097/00007435-199607000-00005  0.201
1994 Boden WE, Moss AJ, Herbert PN, Saritelli A, Oakes D, Eberly S. Brief reportEffect of long-term diltiazem administration on serum lipids in post-myocardial infarction survivors American Journal of Cardiology. 73. PMID 8141095 DOI: 10.1016/0002-9149(94)90685-8  0.199
1999 Baggs JG, Schmitt MH, Mushlin AI, Mitchell PH, Eldredge DH, Oakes D, Hutson AD. Association between nurse-physician collaboration and patient outcomes in three intensive care units. Critical Care Medicine. 27: 1991-8. PMID 10507630 DOI: 10.1097/00003246-199909000-00045  0.199
2022 Shoulson I, Arbatti L, Hosamath A, Eberly SW, Oakes D. Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson's Disease Trials. Journal of Parkinson's Disease. PMID 35694935 DOI: 10.3233/JPD-223274  0.199
1993 Oakes D, Schulzer M, Mak E, Calne DB. Antiparkinson efficacy of deprenyl Annals of Neurology. 34: 634. PMID 8215256 DOI: 10.1002/Ana.410340423  0.199
1997 Oakes D. Selegiline and excess mortality Clinical Neuropharmacology. 20: 542. PMID 9403228 DOI: 10.1097/00002826-199712000-00006  0.198
2008 Hersch S, Rosas HD, Gevorkian S, Oakes D, Matson W. Plasma 8-OH2′dG As a Diagnostic and Pharmacodynamic Biomarker for HD Neurotherapeutics. 5: 367-367. DOI: 10.1016/J.Nurt.2007.10.012  0.196
1997 Baggs JG, Schmitt MH, Mushlin AI, Eldredge DH, Oakes D, Hutson AD. Nurse-Physician Collaboration and Satisfaction with the Decision-making Process in Three Critical Care Units American Journal of Critical Care. 6: 393-399. PMID 9283677 DOI: 10.4037/Ajcc1997.6.5.393  0.195
1999 Shetty N, Friedman JH, Kieburtz K, Marshall FJ, Oakes D. The placebo response in Parkinson's disease Clinical Neuropharmacology. 22: 207-212. PMID 10442249  0.195
1975 Oakes D. Synchronous and Asynchronous Distributions for Poisson Cluster Processes Journal of the Royal Statistical Society Series B-Methodological. 37: 238-247. DOI: 10.1111/J.2517-6161.1975.Tb01539.X  0.194
2005 Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, Tanner CM, Fahn S. High-dosage vitamin E supplementation and all-cause mortality. Annals of Internal Medicine. 143: 152-3; author reply . PMID 16027463 DOI: 10.7326/0003-4819-143-2-200507190-00022  0.193
2013 Ravina B, Marek K, Eberly S, Oakes D, Shoulson I. Reply: Unusual DAT scan results Movement Disorders. 28: 847-847. PMID 23559090 DOI: 10.1002/Mds.25447  0.192
2008 Lichtman MA, Oakes D. ErratumErratum to “The productivity and impact of The Leukemia & Lymphoma Society scholar program: The apparent positive effect of peer review” [Blood Cells Mol. Dis. 27 (2001) 1020–1027] Blood Cells Molecules and Diseases. 41: 236. DOI: 10.1016/J.Bcmd.2008.05.001  0.189
2021 Javidnia M, Arbatti L, Hosamath A, Eberly SW, Oakes D, Shoulson I. Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and Falling. Journal of Parkinson's Disease. PMID 34250951 DOI: 10.3233/JPD-212636  0.189
1997 Oakes D, Oluyede BO. A comment by D. Oakes on OLUYEDE, B. O., 1996: Dependence Functions and Frailties. Biometrical Journal 38, 537—552: Biometrical Journal. 39: 383-384. DOI: 10.1002/Bimj.4710390311  0.188
1985 Oakes D. Self-calibrating priors do not exist Journal of the American Statistical Association. 80: 339. DOI: 10.1080/01621459.1985.10478117  0.184
1997 COOK RJ, LAWLESS JF, OAKES D, DIXON DO, SPIEGEL RJ, LIPSCHUTZ KH, SNAPINN SM, MEHTA CR, SIEGEL JP. DISCUSSION OF PAPER BY WEI AND GLIDDEN Statistics in Medicine. 16: 841-851. DOI: 10.1002/(Sici)1097-0258(19970430)16:8<841::Aid-Sim539>3.0.Co;2-4  0.184
1974 Oakes D, Rade L. Thinning of Renewal Point Processes: A Flow Graph Study. Journal of the American Statistical Association. 69: 1051. DOI: 10.2307/2286196  0.183
2021 Frank S, Testa CM, Stamler D, Kayson E, Oakes D, Vaughan C, Goldstein J, Whaley J, Davis MD, Gordon MF, Savola JM. Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-label Study. Cns Spectrums. 26: 164-165. PMID 34127148 DOI: 10.1017/S1092852920002655  0.179
2005 Siderowf A, Eberly S, Oakes D, Shoulson I. Reexamination of the TEMPO Study—Reply Jama Neurology. 62: 1321-1321. DOI: 10.1001/Archneur.62.8.1321  0.178
2015 Chahine LM, Weintraub D, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26293177 DOI: 10.1002/mds.26373  0.176
2022 Feigin A, Evans EE, Fisher TL, Leonard JE, Smith ES, Reader A, Mishra V, Manber R, Walters KA, Kowarski L, Oakes D, Siemers E, Kieburtz KD, Zauderer M. Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial. Nature Medicine. PMID 35941373 DOI: 10.1038/s41591-022-01919-8  0.176
2000 Marek K, Seibyl J, Holloway R, Kieburtz K, Oakes D, Lang A. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism Neurology. 55: 1540-1547. PMID 11094111  0.173
2020 Mills KA, Schneider RB, Saint-Hilaire M, Ross GW, Hauser RA, Lang AE, Halverson MJ, Oakes D, Eberly S, Litvan I, Blindauer K, Aquino C, Simuni T, Marras C. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism & Related Disorders. 80: 127-132. PMID 32987359 DOI: 10.1016/j.parkreldis.2020.09.028  0.17
2021 Luo S, Zou H, Goetz CG, Choi D, Oakes D, Simuni T, Stebbins GT. Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models. Movement Disorders Clinical Practice. 8: 1083-1091. PMID 34631944 DOI: 10.1002/mdc3.13311  0.169
2023 Chahine LM, Arbatti L, Hosamath A, Amara A, Anderson KE, Purks J, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Standaert DG, Weintraub D, Shoulson I, Marras C. Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptoms. Clinical Parkinsonism & Related Disorders. 9: 100229. PMID 38045566 DOI: 10.1016/j.prdoa.2023.100229  0.167
2024 Mantri S, Purks JL, Kinel D, Arbatti L, Hosamath A, Allen A, Amara A, Anderson K, Chahine LM, Eberly S, Mathur S, Standaert D, Oakes D, Weintraub D, Shoulson I, et al. In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom Database. Journal of Parkinson's Disease. PMID 38669556 DOI: 10.3233/JPD-230305  0.164
2024 Weintraub D, Marras C, Amara A, Anderson KE, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Shoulson I, Arbatti L. Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38318953 DOI: 10.1002/mds.29725  0.158
2022 Luo S, Zou H, Stebbins GT, Schwarzschild MA, Macklin EA, Chan J, Oakes D, Simuni T, Goetz CG. Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35841312 DOI: 10.1002/mds.29154  0.149
2022 Frank S, Testa C, Edmondson MC, Goldstein J, Kayson E, Leavitt BR, Oakes D, O'Neill C, Vaughan C, Whaley J, Gross N, Gordon MF, Savola JM. The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study. Cns Drugs. PMID 36242718 DOI: 10.1007/s40263-022-00956-8  0.149
2022 Feigin A, Evans EE, Fisher TL, Leonard JE, Smith ES, Reader A, Mishra V, Manber R, Walters KA, Kowarski L, Oakes D, Siemers E, Kieburtz KD, Zauderer M. Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial. Nature Medicine. PMID 36195687 DOI: 10.1038/s41591-022-02070-0  0.146
2015 Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, ... ... Oakes D, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease Brain. 138: 2659-2671. DOI: 10.1093/brain/awv202  0.142
2001 Oakes DA, Lieberman JR. Thromboembolism after total hip replacement Current Opinion in Orthopaedics. 12: 71-78. DOI: 10.1097/00001433-200102000-00014  0.14
1998 Lin DY, Oakes D, Ying Z. Additive hazards regression with current status data Biometrika. 85: 289-298.  0.137
2004 Oakes DA, Hanssen AD. Bilateral total knee replacement using the same anesthetic is not justified by assessment of the risks Clinical Orthopaedics and Related Research. 87-91. PMID 15534525 DOI: 10.1097/01.blo.0000147133.75432.86  0.129
1983 Oakes D. Survival analysis European Journal of Operational Research. 12: 3-14. DOI: 10.1016/0377-2217(83)90177-7  0.119
1982 Oakes D, McDonald JC. Restricted cohort study designs Scandinavian Journal of Work, Environment and Health. 8: 30-33. PMID 7100853  0.116
1992 Oakes DF, Manolis AS, Estes NAM. Limited clinical utility of endomyocardial biopsy in patients presenting with ventricular tachycardia without apparent structural heart disease Clinical Cardiology. 15: 24-28. PMID 1541071 DOI: 10.1002/CLC.4960150106  0.114
1988 Dubach P, Froelicher VF, Klein J, Oakes D, Grover-McKay M, Friis R. Exercise-induced hypotension in a male population: Criteria, causes, and prognosis Circulation. 78: 1380-1387. PMID 3191592 DOI: 10.1161/01.CIR.78.6.1380  0.113
1984 Oakes DD, Sherck JP, Brodsky JB, Mark JBD. Therapeutic thoracoscopy Journal of Thoracic and Cardiovascular Surgery. 87: 269-273. PMID 6694418  0.113
2000 Oakes D, Ritz J. Regression in a bivariate copula model Biometrika. 87: 345-352.  0.112
1982 Oakes DD, Sherck JP, Mark JBD. Lye ingestion. Clinical patterns and therapeutic implications Journal of Thoracic and Cardiovascular Surgery. 83: 194-204. PMID 7057663  0.11
1977 Oakes D. Stochastic backtrackings Stochastic Processes and Their Applications. 6: 95-111. DOI: 10.1016/0304-4149(77)90021-7  0.109
1982 Armstrong BG, Oakes D. Effects of approximation in exposure assessments on estimates of exposure-response relationships Scandinavian Journal of Work, Environment and Health. 8: 20-23. PMID 7100851  0.105
2000 Boxall ABA, Oakes D, Ripley P, Watts CD. The application of predictive models in the environmental risk assessment of ECONOR Chemosphere. 40: 775-781. PMID 10705556 DOI: 10.1016/S0045-6535(99)00452-X  0.098
1989 Moss AJ, Oakes D, Benhorin J, Carleen E. The interaction between diltiazem and left ventricular function after myocardial infarction Circulation. 80. PMID 2688978  0.098
2021 Frank S, Vaughan C, Stamler D, Oakes D, Davis MD, Gross N, Gordon MF, Savola JM, Wieman M, Eberly S, Kayson E, Whaley J, Goldstein J, Testa CM. Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease. Cns Spectrums. 26: 162-163. PMID 34127124 DOI: 10.1017/S1092852920002618  0.093
2016 Rich DQ, Peters A, Schneider A, Zareba W, Breitner S, Oakes D, Wiltshire J, Kane C, Frampton MW, Hampel R, Hopke PK, Cyrys J, Utell MJ. Ambient and Controlled Particle Exposures as Triggers for Acute ECG Changes. Research Report (Health Effects Institute). 5-75. PMID 28661614  0.09
1980 Heathcote J, Knauer CM, Oakes D, Archibald RWR. Perforation of an adenocarcinoma of the small bowel affected by regional enteritis Gut. 21: 1093-1096. PMID 7461470  0.086
1998 Gale P, Young C, Stanfield G, Oakes D. Development of a risk assessment for BSE in the aquatic environment Journal of Applied Microbiology. 84: 467-477. PMID 9633645 DOI: 10.1046/j.1365-2672.1998.00495.x  0.085
1998 Ritchie HE, Webster WS, Eckhoff C, Oakes DJ. Model predicting the teratogenic potential of retinyl palmitate, using a combined in vivo/in vitro approach. Teratology. 58: 113-23. PMID 9802191 DOI: 10.1002/(SICI)1096-9926(199809/10)58:3/4<113::AID-TERA7>3.0.CO;2-O  0.083
1997 Oakes DD. Esophagectomy in patients with polysplenia: Technical considerations Journal of Clinical Gastroenterology. 24: 92-96. PMID 9077725 DOI: 10.1097/00004836-199703000-00010  0.082
1984 Harrington JM, Oakes D. Mortality study of British pathologists 1974-80 British Journal of Industrial Medicine. 41: 188-191. PMID 6722045  0.08
1998 Oakes DD, Sherck JP, Cobb LF. Surgical salvage of failed radiocephalic arteriovenous fistulae: Techniques and results in 29 patients Kidney International. 53: 480-487. PMID 9461110 DOI: 10.1046/j.1523-1755.1998.00769.x  0.08
2023 Oakes D. Cox (1972): recollections and reflections. Lifetime Data Analysis. PMID 37713017 DOI: 10.1007/s10985-023-09609-4  0.079
1981 Oakes DD, Charters AC. Changing concepts in the management of splenic trauma Surgery Gynecology and Obstetrics. 153: 181-185. PMID 7244986  0.077
2014 Oakes DA, Eichenbaum KD. Perioperative management of combined carotid and coronary artery bypass grafting procedures Anesthesiology Clinics. 32: 699-721. PMID 25113728 DOI: 10.1016/j.anclin.2014.05.005  0.077
2021 Marras C, Mills KA, Eberly S, Oakes D, Chou KL, Halverson M, Parashos SA, Tarolli CG, Lai JS, Nowinsky CJ, Suchowersky O, Farbman ES, Shulman LM, Simuni T. Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients With Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33983638 DOI: 10.1002/mds.28641  0.076
1985 Oakes DD, Holcomb SF, Sherck JP. Patterns of Trauma Care Costs and Reimbursements: The Burden of Uninsured Motorists Journal of Trauma - Injury, Infection and Critical Care. 25: 740-745. PMID 4020907  0.074
1999 Oakes D. Direct calculation of the information matrix via the EM algorithm Journal of the Royal Statistical Society. Series B: Statistical Methodology. 61: 479-482.  0.072
1985 Kearns PJ, Polhemus RJ, Oakes D, Rabkin R. Hepatorenal syndrome managed with hemodialysis, then reversed by peritoneovenous shunting Journal of Clinical Gastroenterology. 7: 341-343. PMID 4045179  0.072
1980 Oakes DD, Wilmot CB, Halverson D, Hamilton RD. Neurogenic respiratory failure: A 5-year experience using implantable phrenic nerve stimulators Annals of Thoracic Surgery. 30: 118-121. PMID 6968185  0.071
1990 Oakes DD, Wilmot CB, Hall KM, Sherck JP. Benefits of early admission to a comprehensive trauma center for patients with spinal cord injury Archives of Physical Medicine and Rehabilitation. 71: 637-643. PMID 2115765  0.071
2000 Oakes DJ, Pollak JK. The in vitro evaluation of the toxicities of three related herbicide formulations containing ester derivatives of 2,4,5-T and 2,4-D using sub-mitochondrial particles. Toxicology. 151: 1-9. PMID 11074295 DOI: 10.1016/S0300-483X(00)00244-4  0.07
1971 Clarke RM, Hardy RN, Oakes D. Factors influencing the uptake of [ 125 I]polyvinyl pyrrolidone by the intestine of the young rat. The Journal of Physiology. 212: 801-17. PMID 5557072 DOI: 10.1113/jphysiol.1971.sp009357  0.07
2008 Warner R, Ritchie HE, Woodman P, Oakes D, Pourghasem M. The effect of prenatal exposure to a repeat high dose of toluene in the fetal rat. Reproductive Toxicology (Elmsford, N.Y.). 26: 267-72. PMID 18848622 DOI: 10.1016/j.reprotox.2008.09.002  0.067
1979 Rushton KR, Birtles AB, Oakes DB. (Establishment of models on groundwater and surface water interaction) Bulletin, Bureau De Recherches Geologiques Et Minieres, Section Iii,. 3: 293-305.  0.065
2007 Nehme A, Oakes D, Perry MJ, Hawatmeh SI, Trousdale RT. Acetabular morphology in bladder exstrophy complex. Clinical Orthopaedics and Related Research. 458: 125-30. PMID 17308482 DOI: 10.1097/BLO.0b013e3180380ed1  0.065
2010 Meng H, Wamsley BR, Friedman B, Liebel D, Dixon DA, Gao S, Oakes D, Eggert GM. Impact of body mass index on the effectiveness of a disease management-health promotion intervention on disability status. American Journal of Health Promotion : Ajhp. 24: 214-22. PMID 20073389 DOI: 10.4278/ajhp.081216-QUAN-306  0.064
1981 Oakes DB. A numerical model of a stream aquifer system subject to delayed rainfall recharge ( England) Transactions - Geological Society of South Africa. 84: 135-144.  0.064
2000 Oakes DA, Lieberman JR. Osteoinductive applications of regional gene therapy: Ex vivo gene transfer Clinical Orthopaedics and Related Research. PMID 11039758  0.063
1981 Liddament MW, Oakes DB, Skinner AC, Wilkinson WB. The use of a groundwater model in the design, performance assessment, and operation of a river regulation scheme ( Severn River) Logistics and Benefits of Using Mathematical Models of Hydrologic and Water Resource Systems. Selected Papers, Symposium, Pisa 1978. 149-166.  0.062
1981 Oakes DB, Young CP, Foster SSD. The effects of farming practices on groundwater quality in the United Kingdom Science of the Total Environment, The. 21: 17-30. DOI: 10.1016/0048-9697(81)90132-7  0.06
1969 Oakes DD, Schreibman PH, Hoffman RS, Arky RA. Hyperglycemic, nonketotic coma in the patient with burns: Factors in pathogenesis Metabolism. 18: 103-109. PMID 5766385  0.06
1995 Oakes DD. Editorial: Reconsidering the diagnosis and treatment of patients following ingestion of liquid lye Journal of Clinical Gastroenterology. 21: 85-86. PMID 8583091  0.059
1993 Clark L, Gomme J, Oakes DB. Pesticide transport investigations in the major aquifers of the UK Water Supply. 11: 19-30.  0.059
1976 Young CP, Oakes DB, Wilkinson WB. Prediction of future nitrate concentrations in ground water Ground Water. 14: 426-438. DOI: 10.1111/j.1745-6584.1976.tb03136.x  0.059
1980 Oakes DB. NUMERICAL MODEL OF A STREAM AQUIFER SYSTEM SUBJECT TO DELAYED RAINFALL RECHARGE Verhandelinge Van Die Geologiese Vereniging Van Suid-Afrika. 84: 135-144.  0.058
1996 Norton RL, Oakes DB, Cole JA. Pollution risk management for resource protection Water Science and Technology. 33: 119-131. DOI: 10.1016/0273-1223(96)00194-1  0.057
1999 Oakes DJ, Pollak JK. Effects of a herbicide formulation, Tordon 75D®, and its individual components on the oxidative functions of mitochondria Toxicology. 136: 41-52. PMID 10499849 DOI: 10.1016/S0300-483X(99)00055-4  0.056
1975 Oakes DD, Couch NP. A New Use for Catheter Duodenostomy: Postoperative Enteric Alimentation Archives of Surgery. 110: 845-846. PMID 806276 DOI: 10.1001/archsurg.1975.01360130077018  0.056
2003 Oakes DA, McAllister DR. Failure of heat shrinkage for treatment of a posterior cruciate ligament tear Arthroscopy : the Journal of Arthroscopic &Amp; Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 19. PMID 12861215 DOI: 10.1016/50749-8063(03)00377-3  0.055
1998 Sherck J, Shiver A, Shatney C, Oakes D, Cobb L. Covering the 'open abdomen': A better technique American Surgeon. 64: 854-857. PMID 9731813  0.054
1979 Rushton KR, Birtles AB, Oakes DB. Development of Models of Groundwater Flows and the Flow Interaction with Surface Water Bulletin Du Bureau De Recherches Geologiques Et Minieres. Section 3, Hydrogeologie. 293-305.  0.054
1973 Colquhoun B, Oakes D, Gold P. The metabolism of alpha 1 fetoprotein in the rat Clinical Research. 21: 644.  0.054
2012 Gunnström M, Ababneh D, Webster WS, Oakes D, Ritchie H. Antipsychotic drugs cause bradycardia in GD 13 rat embryos in vitro. Reproductive Toxicology (Elmsford, N.Y.). 34: 443-50. PMID 22750488 DOI: 10.1016/j.reprotox.2012.06.008  0.053
1977 Oakes DD, Weidig JC, Spees EK, Light JA. Another view on treatment for uremic pericardial effusion Surgery. 82: 894. PMID 929376  0.05
2007 Rawlins WT, Oakes DB, Davis SJ. Hyperspectral infrared imaging of HF(v, J) chemiluminescence and gain in chemically reacting flowfields. The Journal of Physical Chemistry. A. 111: 6860-9. PMID 17518458 DOI: 10.1021/jp071786r  0.049
1980 Charters AC, Oakes DD, Froehlich JP. Effect of hepatectomy on mitotic activity in the rat spleen Journal of Surgical Research. 29: 331-337. PMID 7412269  0.049
1984 Sherck JP, McCort JJ, Oakes DD. Computed tomography in thoracoabdominal trauma Journal of Trauma - Injury, Infection and Critical Care. 24: 1015-1021. PMID 6512895  0.049
1979 Oakes DB. The movement of water and solutes through the unsaturated zone of the chalk in the United Kingdom Surface and Subsurface Hydrology. Proc. Fort Collins 3rd International Hydrology Symposium, July 1977. 447-459.  0.047
2006 Vessely MB, Frick MA, Oakes D, Wenger DE, Berry DJ. Magnetic resonance imaging with metal suppression for evaluation of periprosthetic osteolysis after total knee arthroplasty. The Journal of Arthroplasty. 21: 826-31. PMID 16950034 DOI: 10.1016/j.arth.2005.10.017  0.047
2006 Oakes DA, Cabanela ME. Impaction bone grafting for revision hip arthroplasty: biology and clinical applications. The Journal of the American Academy of Orthopaedic Surgeons. 14: 620-8. PMID 17030595  0.045
1977 Oakes DB, Edworthy KJ. Field measurements of dispersion coefficients in the United Kingdom .  0.044
1996 Maki-Ikola O, Heinonen E, Penney JB, Shoulson I, Kieburtz K, Oakes D. Study design problems of DATATOP study analysis [2] Annals of Neurology. 40: 946-948. PMID 9007106 DOI: 10.1002/ana.410400624  0.043
1982 Spees EK, Light JA, Oakes DD, Reinmuth B. Experiences with cadaver renal allograft contamination before transplantation British Journal of Surgery. 69: 482-485. PMID 7049310  0.041
2019 Dua A, Rothenberg KA, Lavingia K, Oakes DD, Sorial E, Garcia-Toca M. Long-term durability of Oakes salvage procedure to preserve Brescia-Cimino arteriovenous fistula. Journal of Vascular Surgery. PMID 30837176 DOI: 10.1016/j.jvs.2018.12.034  0.041
1982 Oakes DD, Froehlich JP, Charters AC. Intraportal splenic autotransplantation in rats: Feasibility and effectiveness Journal of Surgical Research. 32: 7-14. PMID 7054600 DOI: 10.1016/0022-4804(82)90178-0  0.041
2000 Wolff EG, Chen H, Oakes DW. Hygrothermal deformation of composite sandwich panels Advanced Composites Letters. 9: 35-43.  0.041
1979 Oakes DB. Modelling of groundwater quality processes Hydrological Sciences Bulletin. 24: 161-165. DOI: 10.1080/02626667909491851  0.04
1986 Nguyen TD, Oakes D, Fogel MR, Williams L, Sherck JP, Kozar M. Hepatocellular adenoma and nodular regenerative hyperplasia of the liver in a young man Journal of Clinical Gastroenterology. 8: 478-482. PMID 3020120  0.04
1990 Sherck JP, Oakes DD. Intestinal injuries missed by computed tomography Journal of Trauma - Injury, Infection and Critical Care. 30: 1-7. PMID 2296055  0.04
2002 Hame SL, Oakes DA, Markolf KL. Injury to the anterior cruciate ligament during alpine skiing: A biomechanical analysis of tibial torque and knee flexion angle American Journal of Sports Medicine. 30: 537-540. PMID 12130408  0.04
1996 Caledonia GE, Krech RH, Oakes DB. Laboratory simulation of Low Earth Orbit (LEO) atomic oxygen effects Journal of the Institute of Environmental Sciences. 39: 23-28.  0.038
2002 Oakes DD, Adams GA, Sherck JP, Guest SS. A new operation with inadequate Brescia fistulae for preservation of more proximal veins. Journal of Vascular Surgery. 36: 346-50. PMID 12170217 DOI: 10.1067/mva.2002.125750  0.038
1974 Downing RA, Oakes DB, Wilkinson WB, Wright CE. Regional development of groundwater resources in combination with surface water Journal of Hydrology. 22: 155-177. DOI: 10.1016/0022-1694(74)90102-4  0.038
2001 Read M, Oakes D, Kremer M, Gelb A, Davis WSAS. Microwave driven torches for high temperature chemistry and production of atomic species Ieee International Conference On Plasma Science.  0.037
1959 Schamp HW, Oakes DA, Reed NM. Grinder for sectioning solid diffusion specimens Review of Scientific Instruments. 30: 1028-1031. DOI: 10.1063/1.1716412  0.037
1972 Oakes DD, Shuster J, Gold P. Radioimmunoassay for α1-Fetoprotein in the Serum of Rats Cancer Research. 32: 2753-2760. PMID 4630092  0.036
2005 Hamadouche M, Oakes DA, Berry DJ. Bone grafting for total joint arthroplasty: Biology and clinical applications Bone Regeneration and Repair: Biology and Clinical Applications. 263-289. DOI: 10.1385/1-59259-863-3:263  0.035
1987 Oakes D. Practical applications of solvent emission control using activated carbon .  0.035
2022 Treichler EBH, Mercado R, Oakes D, Perivoliotis D, Gallegos-Rodriguez Y, Sosa E, Cisneros E, Spaulding WD, Granholm E, Light GA, Rabin B. Using a stakeholder-engaged, iterative, and systematic approach to adapting collaborative decision skills training for implementation in VA psychosocial rehabilitation and recovery centers. Bmc Health Services Research. 22: 1543. PMID 36528579 DOI: 10.1186/s12913-022-08833-2  0.033
2005 Rawlins WT, Hensley JM, Sonnenfroh DM, Oakes DB, Allen MG. Quantum cascade laser sensor for SO2 and SO3 for application to combustor exhaust streams. Applied Optics. 44: 6635-43. PMID 16270552  0.033
2002 Markolf KL, Hame SL, Monte Hunter D, Oakes D, Gause P. Biomechanical effects of femoral notchplasty in anterior cruciate ligament reconstruction American Journal of Sports Medicine. 30: 83-89. PMID 11799001  0.033
2023 Treichler EBH, Reznik SJ, Oakes D, Girard V, Zisman-Ilani Y. Military culture and collaborative decision-making in mental healthcare: cultural, communication and policy considerations. Bjpsych Open. 9: e154. PMID 37578050 DOI: 10.1192/bjo.2023.516  0.033
2002 Rawlins WT, Oakes DB, Mulhall PA, Davis SJ. Imaging spectroradiometer for HF laser studies Proceedings of Spie - the International Society For Optical Engineering. 4631: 217-224. DOI: 10.1117/12.465770  0.03
2003 Oakes DA, Lee CC, Lieberman JR. An Evaluation of Human Demineralized Bone Matrices in a Rat Femoral Defect Model Clinical Orthopaedics and Related Research. 281-290. PMID 12897620  0.029
1993 Oakes DJ, McCoustra MRS, Chesters MA. Dissociative adsorption of methane on Pt(111) induced by hyperthermal collisions Faraday Discussions. 96: 325-336. DOI: 10.1039/Fd9939600325  0.028
1997 Oakes DD, Sherck JP. Repair of a post-traumatic common iliac arteriovenous fistula Cardiovascular Surgery. 5: 328-333. PMID 9293370 DOI: 10.1016/S0967-2109(97)00020-3  0.028
1995 Oakes DB, Krech RH, Upschulte BL, Caledonia GE. Oxidation of polycrystalline silver films by hyperthermal oxygen atoms Journal of Applied Physics. 77: 2166-2172. DOI: 10.1063/1.358794  0.028
1966 Oakes D, Serino A. An automatic device for collecting dust-free precipitation. Health Physics. 12: 574-6. PMID 5960277  0.026
2006 Fanning MF, Oakes DW. A tool for quantifying organizational support for evidence-based practice change. Journal of Nursing Care Quality. 21: 110-3. PMID 16540776  0.026
2007 Wolff EG, Oakes DW. Measurement of hygrothermal expansion of asymmetric composite panels Iccm International Conferences On Composite Materials.  0.026
2009 Saperstein S, Chen L, Oakes D, Pryhuber G, Finkelstein J. IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 29: 273-84. PMID 19231998 DOI: 10.1089/Jir.2008.0076  0.026
1982 Oakes DD, Sherck J. Splenic Trauma, Splenosis, and Death From Sepsis Jama: the Journal of the American Medical Association. 247: 1404-1405. PMID 7057522 DOI: 10.1001/jama.1982.03320350018006  0.025
1981 Oakes DD, Spees EK, McAllister HA, Saddler W. Arterial injury during perfusion preservation: A possible cause of posttransplantation renal artery stenosis Surgery. 89: 210-215. PMID 7006135  0.024
2002 Davis SJ, Oakes DB, Read ME, Gelb AH. Atomic fluorine source for chemical lasers Proceedings of Spie - the International Society For Optical Engineering. 4631: 178-183. DOI: 10.1117/12.465780  0.024
2009 Oakes DA, Mangano CT. Cardiopulmonary bypass in 2009: achieving and circulating best practices. Anesthesia and Analgesia. 108: 1368-70. PMID 19372307 DOI: 10.1213/ane.0b013e31819d657e  0.023
1983 Oakes D. Comment Journal of the American Statistical Association. 78: 288. DOI: 10.1080/01621459.1983.10477964  0.021
1982 Spees EK, Oakes DD, Hill GS. Some preserved kidneys do not function: A review of preservation-related endothelial injuries Transplantation Proceedings. 14: 80-85.  0.021
1977 Oakes DD, Weidig JC, Spees EK, Light JA. Topical Steroids for Uremic Pericardial Effusions Jama: the Journal of the American Medical Association. 238: 1721. PMID 578260 DOI: 10.1001/jama.1977.03280170015006  0.02
1975 Oakes DD, Wilson RE. Malposition of a Subclavian Line: Resultant Pleural Effusions, Interstitial Pulmonary Edema, and Chest Wall Abscess During Total Parenteral Nutrition Jama: the Journal of the American Medical Association. 233: 532-533. PMID 806715 DOI: 10.1001/jama.1975.03260060042017  0.017
2005 Nehme A, Maalouf G, Oakes D, Ghantous I, Trousdale RT. Persistent bladder entrapment following acetabular fracture with subsequent vesical injury during total hip arthroplasty. A case report. The Journal of Bone and Joint Surgery. American Volume. 87: 870-3. PMID 15805219 DOI: 10.2106/JBJS.D.02029  0.015
2000 Oakes DD. Creating and maintaining autologous arteriovenous fistulae: The importance of surgical salvage International Journal of Artificial Organs. 23: 17-19. PMID 12118832  0.014
1981 Oakes DD, Spees EK, Light JA. Renovascular hypertension after transplantation of a kidney perfused via multiple renal arteries American Surgeon. 47: 272-274. PMID 7018334  0.014
1949 Cole JA, Oakes DB, Slade S, Clark KJ. Potential impacts of climatic change and of sea-level rise on the yields of aquifer, river and reservoir sources Journal of the Chartered Institution of Water and Environmental Management. 8: 591-606. DOI: 10.1111/j.1747-6593.1994.tb01156.x  0.014
2000 Oakes D. Academic medicine and managed care: a unique collaboration Cost &Amp; Quality : Cq. 6: 24-26. PMID 10788215  0.013
1981 Allibone A, Oakes D, Shannon HS. The health and health care of doctors Journal of the Royal College of General Practitioners. 31: 728-734. PMID 7338866  0.012
2015 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Author Response. Neurology. 84: 2292. PMID 26230002  0.012
2004 Read M, Schwarz W, Oakes D. Application of a Microwave-Driven Plasma Torch to thermal chemistry Ieee International Conference On Plasma Science. 307.  0.011
2005 Rawlins WT, Oakes DB, Davis SJ. Hyperspectral infrared imaging of HF(v,J) chemiluminescence and gain in chemically reacting flowfields 36th Aiaa Plasmadynamics and Lasers Conference.  0.01
2001 Oakes DA, McAllister DR. An atypical appearance of a posterior dislocation of the shoulder with a fracture of the proximal humerus Journal of Shoulder and Elbow Surgery. 10: 182-185. PMID 11307083 DOI: 10.1067/mse.2001.110512  0.01
1981 Oakes DD. Splenic trauma Current Problems in Surgery. 18: 341-401. PMID 7018844 DOI: 10.1016/S0011-3840(81)80001-9  0.01
1980 Charters AC, Oakes DD, Froehlich J. The effect of endogenous estrogen on liver regeneration in the rat Gastroenterology. 78: 1304.  0.01
1980 Thomson WJ, Gerber MA, Hatter MM, Oakes DG. KINETICS OF OIL SHALE CHAR GASIFICATION Acs Division of Fuel Chemistry, Preprints. 25: 98-101.  0.01
1979 Spees EK, Oakes DD, McAllister HA. Renal artery stenosis after machine preservation and transplantion of cadaver kidneys Surgery. 86: 907-908. PMID 390755  0.01
1961 Renfrow WB, Oakes D, Lauer C, Walter TA. Synthesis of substituted tetrahydrofurans. An application of the Grignard reagent from 3-bromo-1-(1,1-dimethylpropoxy)-propane Journal of Organic Chemistry. 26: 935-937.  0.01
Hide low-probability matches.